Provider: ValuEngine, Inc.
Actelion Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Actelion Ltd Proposes To Increase Dividend Payment
Actelion Ltd announced that Board proposes to increase the dividend payment to CHF 1.00 from CHF 0.80 per share and will ask for shareholder approval to do so at the upcoming Annual General Meeting on April 18, 2013.
Latest Developments for Actelion Ltd
Latest Key Developments in Biotechnology
- Proteon Therapeutics Inc announces pricing of Initial Public Offering
- Esperion Therapeutics Inc announces closing of follow-on public offering and exercise in full of underwriters' option to purchase additional shares of common stock
- Repros Therapeutics announces results from long-term study of Androxal(R) Exhibit positive safety profile
- Share this
- Digg this